CD40L expressed by CD8+ T cells may either engage in the traditional cross-talk with host CD40+ antigen-presenting cells to enhance antitumor immunity or induce CD40-dependent noncanonical cytotoxicity in CD40+ cancer cells. This evidence concerns the gene CD8A and cancer.